Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome

Human Reproduction

Volumn 22, Issue 4, 2007, Pages 1100-1106

  Seow, Kok Min ^a,b,c   Juan, Chi Chang ^c,d   Ho, Low Tone ^c,d   Hsu, Yung Pei ^d   Lin, Yu Hung ^a,b   Huang, Lee Wen ^a,b   Hwang, Jiann Loung ^a,b,e  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adipocyte; Insulin resistance; Laparoscopic ovarian electrocauterization; Polycystic ovary syndrome; Resistin

Indexed keywords

BETA ACTIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; MESSENGER RNA; RESISTIN; TESTOSTERONE;

ADIPOCYTE; ADULT; ARTICLE; CAUTERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LAPAROSCOPIC OVARIAN ELECTROCAUTERIZATION; LAPAROSCOPY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BODY MASS; CYTOLOGY; DOWN REGULATION; GENE EXPRESSION REGULATION; METABOLISM; OVARY; PATHOLOGY;

ADIPOCYTES; BODY MASS INDEX; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LAPAROSCOPY; OBESITY; OVARY; POLYCYSTIC OVARY SYNDROME; RESISTIN; RNA, MESSENGER;

EID: 34347262092     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del489     Document Type: Article

References (40)

1. Amer SAK, Banu Z, Li TC and Cooke ID (2002) Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes. Hum Reprod 17,2851-2857.
2. Balen AH, Laven JS, Tan SL and Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9,505-514.
3. Burghen GA, Givens JR and Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50,113-116.
4. Campo S, Felli A, Lamanna MA, Barini A and Garcea N (1993) Endocrine changes and clinical outcome after laparoscopic ovarian resection in women with polycystic ovaries. Hum Reprod 8,359-363.
5. Dunaif A (1992) Polycystic ovary syndrome and obesity. In Bjorntorp P and Brodoff BN (eds) Obesity. JB Lippincott Co, Philadelphia, 594 pp.
6. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18,774-800.
7. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W and Lewy L (1991) Acanthosis nigricans, insulin action and hyperandrogenism: clinical, histological and biochemical findings. J Clin Endocrinol Metab 73,590-595.
8. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333,853-861.
9. Frohlich AD (2003) Clinical implications of local renin-angiotensin- aldosterone systems. Curr Cardiol Rep 5,247-248.
10. Gjonnaess H (1998) Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril 69,697-701.
11. Grulet H, Hecart AC, Delemer B, Gross A, Sulmont V, Leutenegger M and Caron J (1993) Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf) 38,621-626.
12. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E and Smith SR (2004) Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89,1844-1848.
13. Hironori A, Ikuko K, Shizuka K, Hiroyuki N, Tetsuo M and Yasunori Y (2002) Laparoscopic treatment of polycystic ovaries with the Holmium: YAG laser. Fertil Steril 77,852-853.
14. Hwang JL, Seow KM, Lin YH, Huang LW, Hsieh BC, Tsai YL, Wu GJ, Huang SC, Chen CY, Chen PH et al. (2004) Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study. Hum Reprod 19(9),1993-2000.
15. Kauffman RP, Baker VM, Dimarino P, Gimpel T and Castracane VD (2002) Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 187,1362-1369.
16. Legro RS, Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84,165-169.
17. Lemieux S, Lewis GF, Ben-Chetrit A, Steiner G and Greenblatt EM (1999) Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. J Clin Endocrinol Metab 84,4278-4282.
18. Lewandowski KC, Szosland K, O'Callaghan C, Tan BK, Randeva HS and Lewinski A (2005) Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab 85,61-69.
19. Li TC, Saravelos H, Chow MS, Chisabingo R and Cooke ID (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovary syndrome in women with anovulatory infertility. Br J Obstet Gynecol 105,338-344.
20. Ling C, Kindblom J, Wennbo H and Billig H (2001) Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Lett 507,147-150.
21. Lobo RA, Gysler M, March CM, Goebelsmann U and Mishell DR (1982) Clinical and laboratory predictors of clomiphene response. Fertil Steril 37,168-174.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: insulin resistance and [beta]-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28,412-419.
23. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH and Kumar S (2002) Resistin, central obesity and type 2 diabetes. Lancet 359,46-47.
24. Naether OG, Baukloh V, Fischer R and Kowalczyk T (1994) Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface. Hum Reprod 9,2342-2349.
25. Nagaev I and Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285,561-564.
26. Nestler JE, Jakubowicz DJ, Evans WS and Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338,1876-1880.
27. Rajala MW, Obici S, Scherer PE and Rossetti L (2003) Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 111,225-230.
28. Rodbell M (1964) Metabolism of isolated fat cell. I. Effects of hormone on glucose metabolism and lipolysis. J Biol Chem 239,375-380.
29. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19,41-47.
30. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV and O'Rahilly S (2001) Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferator-activated receptor-[gamma] action in humans. Diabetes 50,2199-2202.
31. Saleh A, Morris D, Tan SL and Tulandi T (2001) Effects of laparoscopic ovarian drilling on adrenal steroids in polycystic ovary syndrome patients with and without hyperinsulinemia. Fertil Steril 75,501-504.
32. Sample WF, Lippe BM and Gyepes MT (1977) Gray-scale ultrasonography of the normal female pelvis. Radiology 125,477-483.
33. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U and Baroni MG (2002) Human resistin gene, obesity and type 2 diabetes: mutation analysis and population study. Diabetes 51,860-862.
34. Seow KM, Juan CC, Wu LY, Yang WM, Tsai YL, Hwang JL and Ho LT (2004) Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod 19,48-53.
35. Stein IF and Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29,181-191.
36. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wirght CM, Patel HR, Ahima RS and Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409,307-312.
37. Tiitinen A, Tenhunen A and Seppala M (1993) Ovarian electrocauterization causes LH-regulated but not insulin-regulated endocrine changes. Clin Endocrinol (Oxf) 39,181-184.
38. Tulandi T, Watkin K and Tan SL (1997) Reproductive performance and three dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling. Int J Infertil 42,436-440.
39. Wang H, Chu WS, Hemphill C and Elbein SC (2002) Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87,2520-2524.
40. Wu MH, Huang MF, Tsai SJ, Pan HA, Cheng YC and Lin YS (2004) Effects of laparoscopic ovarian drilling on young adult women with polycystic ovarian syndrome. J Am Assoc Gynecol Laparosc 11,184-190.